Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China

President Donald Trump has amended a previous executive order to address the synthetic opioid supply chain from China by modifying the conditions under which certain goods can receive duty-free treatment. This change removes duty-free status once the Secretary of Commerce confirms that systems are in place to collect tariff revenues effectively. The amendment aims to strengthen tariff enforcement, potentially impacting the flow of synthetic opioids and increasing revenue, while also holding legal implications for trade law enforcement and international economic relations.